Medical (clinical) nutrition market trends by type (pediatric nutrition, parenteral nutrition, elderly nutrition and sports nutrition), product type (amino acid solutions, multiple vitamins and antioxidants, lipid emulsions, trace elements and chamber bags) And insight management (parenteral and oral), applications (pediatric malnutrition, gastrointestinal disorders, renal failure, cancer, lung disorders, diabetes and neurological disorders), distribution channels (hospitals, combination pharmacies, retail pharmacies), competitive markets Growth, scale, share and forecast until 2027
Overview of the medical nutrition market
According to a comprehensive research report by Market Research Future (MRFR), Medical nutrition market Information by type, product type, route of administration, application, distribution channel, and region-2027 forecast“The market will reach US $ 64.28 billion with a CAGR of 5.4% by 2027.
Overview of the medical (clinical) nutrition market
Due to the overwhelming problem of malnutrition, the medical (clinical) nutrition market needs to address the nutritional needs of patients. Medical nutrition is essential for chronic diseases such as chronic obstructive pulmonary disease (COPD), diabetes, cancer, immune system problems, and gastrointestinal disorders. Increasing knowledge of medical foods and beverages and rising disease rates are driving the medical nutrition industry forward. Clinical dietary supplements are a type of drug that helps patients’ health, including helping the necessary supplements such as minerals, vitamins, and other nutrients improve the metabolic system.
Clinical nutrition promotes health by diagnosing and treating disorders that affect intestinal absorption, dietary intake, metabolism, and prevention of diet-related illnesses. If nutrient absorption or food intake is restricted for a long period of time, clinical nutrition therapy is essential to avoid famine and other serious effects. Patients suffering from chronic illness are deficient in some important nutrients, which encourages an increase in clinical nutritional prescriptions. In addition, industry growth is driven by a surge in the obese population due to poor diet and lack of exercise.
Scope of report:
|Market size||US $ 64.28 billion|
|Prediction unit||Value (US $ 1 billion)|
|Report coverage||Revenue forecasts, competitive landscapes, growth factors, and trends|
|Target segment||By type, by product type, by route of administration, application, by distribution channel|
|Target area||North America, Europe, Asia Pacific, and other regions (RoW)|
|Major market drivers||Raising awareness of the nutritional value of babies is also a factor|
|Increased fast food consumption and lifestyle changes|
Competitive landscape of the clinical nutrition market:
The well-known competitors in the medical (clinical) nutrition market are:
- AYMES Nutrition International Ltd. (UK)
- Mead Johnson and Company, LLC. (we)
- Primus Pharmaceuticals (US)
- Nutricia Advanced Medical Nutrition (Netherlands)
- Solace Nutrition (UK)
- Abbott Nutrition (USA)
- Baxter International (USA)
- Nestle Health Sciences (Switzerland)
- Braun Melsungen AG (Germany)
- NeoMed (USA)
- Danone (France)
Target clinical nutrition market USP:
Changes in eating habits and lifestyles, such as long working hours and smoking, have reduced the absorption of nutrients, resulting in tremendous growth in the medical nutrition sector. Medical nutritional value should increase as more individuals become informed about their nutritional value and the need for adequate nutrition. Market growth is also supported by growing awareness of the importance of the medical nutrition market.
Government rules are putting pressure on the health and nutrition market in some countries. The health and nutrition sector is hampered by inadequate reimbursement regulations enacted by various governments. In addition, the global expansion of the medical nutrition market is constrained by lack of information and strict regulations. Lack of understanding, especially in emerging markets, and strict control rules are only a few barriers that may limit the use of alternative nutritional methods. Lack of adoption of modern approaches and refusal of streamlined methods of nutrition consumption can hinder the expansion of the clinical nutrition industry in the least developed countries of the world, where living standards are significantly lower.
Clinical nutrition is important during surgery because it allows specialists to work in a confined manner while minimizing adverse effects on the patient. As a result of the increased illness burden and surgical volume, the clinical nutrition market is projected to grow throughout the forecast period.
Clinical nutrition market COVID 19 analysis
The COVID-19 pandemic poses an unexpected public health threat that has a significant impact on the clinical nutrition industry. Millions of people are affected by the coronavirus outbreak, resulting in high mortality. The long-term COVID-19 pandemic and state-wide blockade in many countries is affecting the therapeutic nutrition sector. However, patients with COVID-19 frequently require dietary supplements with some micronutrients and major nutrients, increasing nutritional treatment requirements. The COVID-19 pandemic has the potential to have a significant impact on the clinical nutrition product market, especially as the need for nutritional management continues to grow, especially among the young and the elderly.
In addition, the lack of nutritional importance of COVID-19 can have a significant impact on a patient’s prognosis. As a result, hospitals and clinics are well equipped to provide medical care to patients in need of disease-specific nutrition. These advances will drive the adoption of clinical nutrition management among patients and will soon drive industry trends.
Medical nutrition market segmentation
Increased preterm births in countries such as India and China are driving demand for the pediatric nutrition segment.
By product type
The amino acid solutions segment has the highest market share.
By management route
During the forecast period, the oral segment is expected to gain traction.
The cancer segment will have a large share during the forecast period. The market is projected to be driven by an increase in the number of patients experiencing chronic diseases such as cancer and diabetes during the forecast period and an increase in the elderly population base.
By distribution channel
Over the next few years, the hospital segment will gain valuable market share.
Health and nutrition market area insights
The Asia Pacific region is the largest consumer of clinical nutrition products in the world. Both India and China have high birth rates and are expected to increase global demand for clinical nutrition products, especially nutritional products for newborns. With strong R & D costs, the presence of key companies, the availability of their products, and the well-established healthcare infrastructure in the region, North America is expected to maintain its advantage. However, as the Asian government is investing in the construction of medical infrastructure, the Asia Pacific region is projected to have the highest CAGR during the forecast period.
Compared to other regions, North America contributes significantly to market growth. Increasing prevalence of metabolic diseases and increasing aging population are two main reasons for driving the clinical nutrition industry.